Immuneel Therapeutics launches global CAR T-cell therapy for Lymphoma in India
- Posted on January 20, 2025
- By Financial Express
- 1 Views
Immuneel Therapeutics launches global CAR T-cell therapy for Lymphoma in India
Immuneel Therapeutics has launched Qartemi, an affordable and personalized CAR T-cell therapy for adult patients with relapsed or refractory B-cell Non-Hodgkin Lymphoma (B-NHL) in India. This groundbreaking therapy, benchmarked to global standards, aims to address the rising burden of blood cancers in the country.
